<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37505302</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Multiple eruptive dermatofibromas associated with altered immunity and systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>2917</StartPage><EndPage>2918</EndPage><MedlinePgn>2917-2918</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-023-06705-6</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Po-Chien</ForeName><Initials>PC</Initials><Identifier Source="ORCID">0000-0002-2218-6083</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center of Big Data and Meta-Analysis, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hung</LastName><ForeName>Yi-Teng</ForeName><Initials>YT</Initials><Identifier Source="ORCID">0000-0003-1759-7790</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wei-Ti</ForeName><Initials>WT</Initials><Identifier Source="ORCID">0000-0002-1929-4008</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan. greatedisonchen@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan. greatedisonchen@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Chang Gung University, Taoyuan, Taiwan. greatedisonchen@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VNUS Dermatology Clinic, Taipei, Taiwan. greatedisonchen@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018219" MajorTopicYN="Y">Histiocytoma, Benign Fibrous</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012878" MajorTopicYN="Y">Skin Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005076" MajorTopicYN="Y">Exanthema</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Immunosuppressants</Keyword><Keyword MajorTopicYN="N">Multiple eruptive dermatofibromas</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>13</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>11</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37505302</ArticleId><ArticleId IdType="doi">10.1007/s10067-023-06705-6</ArticleId><ArticleId IdType="pii">10.1007/s10067-023-06705-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang PY, Chu CY, Hsiao CH (2007) Multiple eruptive dermatofibromas in a patient with dermatomyositis taking prednisolone and methotrexate. J Am Acad Dermatol 57:S81&#x2013;S84</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2006.05.070</ArticleId><ArticleId IdType="pubmed">17097372</ArticleId></ArticleIdList></Reference><Reference><Citation>Seifi G, Kalantari Y, Etesami I (2022) Multiple dermatofibromas, associated clinical and histological characteristics: a systematic review. J Dtsch Dermatol Ges 20:1569&#x2013;1579</Citation><ArticleIdList><ArticleId IdType="pubmed">36508383</ArticleId></ArticleIdList></Reference><Reference><Citation>Niiyama S, Katsuoka K, Happle R, Hoffmann R (2002) Multiple eruptive dermatofibromas: a review of the literature. Acta Derm Venereol 82:241&#x2013;244</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/000155502320323171</ArticleId><ArticleId IdType="pubmed">12361125</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins L, Quinn A, Stasko T (2019) Skin cancer and immunosuppression. Dermatol Clin 37:83&#x2013;94</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.det.2018.07.009</ArticleId><ArticleId IdType="pubmed">30466691</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunawardane ND, Dontsi M, Lyon LL (2020) Risk of non-melanoma skin cancer in connective tissue disease and the impact of immunosuppressive therapy. J Drugs Dermatol 19:519&#x2013;523</Citation><ArticleIdList><ArticleId IdType="doi">10.36849/JDD.2020.4781</ArticleId><ArticleId IdType="pubmed">32484614</ArticleId></ArticleIdList></Reference><Reference><Citation>Estela JR, Rico MT, Perez A, Unamuno B, Garcias J, Cubells L, Alegre V (2014) Dermatofibroma of the face: a clinicopathologic study of 20 cases. Actas Dermosifiliogr 105:172&#x2013;177</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ad.2013.10.002</ArticleId><ArticleId IdType="pubmed">24275565</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelger B, Zelger BG, Burgdorf WH (2004) Dermatofibroma&#x2014;a critical evaluation. Int J Surg Pathol 12:333&#x2013;344</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/106689690401200406</ArticleId><ArticleId IdType="pubmed">15494859</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>